mixngo the disruptive technology, page-3

And the Executive Chairman and acting CEO of Quanterix, Dr. Martin Madaus, Ph.D, was previously President, CEO and head of North American Operations for Roche Diagnostics Corporation. Prior to this he served as Vice President of Business Development for Roche Molecular Diagnostics. http://www.quanterix.com/company/index.html

Read into that what you will, but apart from anything else I would suggest that Geoff personally would be very keen on seeing the detection rates of prostrate cancer improved, following a discussion I had with him about my own terminally-ill father.